Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo.
about
Targeting the intragraft microenvironment and the development of chronic allograft rejectionSU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulationImmunotherapy targets in pediatric cancer.The cutaneous vascular system in chronic skin inflammationVEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipientsInduction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.DEPTOR regulates vascular endothelial cell activation and proinflammatory and angiogenic responses.Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following TransplantationNeuropilin 1: function and therapeutic potential in cancer.Chronic allograft rejection: a fresh look.Neuropilin-1 as Therapeutic Target for Malignant Melanoma.The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance.Neuropilin-1 Is Expressed on Lymphoid Tissue Residing LTi-like Group 3 Innate Lymphoid Cells and Associated with Ectopic Lymphoid AggregatesAn isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.Netrin-1 Augments Chemokinesis in CD4+ T Cells In Vitro and Elicits a Proinflammatory Response In Vivo.Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.Leukocyte trafficking is not affected by multikinase inhibitors sunitinib or sorafenib in mice.Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.
P2860
Q26852762-3862C410-EF4E-447C-B46C-A42D0505773FQ28483604-A80833AC-4BD1-40F4-86AA-35811BD2C40DQ35971029-809F01D6-CD23-4398-8906-56DAB029146BQ36098582-AFAC595E-4FBC-44D4-9B31-8E4D3734311DQ36684948-A5CDDE2B-3B12-4D46-8523-E82E670951CEQ37104090-DDE52117-5A32-4ED1-8CE9-4CA102F52259Q37151705-3F28B21D-1126-4E66-9E33-F986FA898574Q38008362-0721B2E4-9B49-46DF-90CE-C22B007FA4D8Q38165001-F1D676FB-ADEC-4379-81AD-52BD6936CE71Q38309271-D70C3EDE-B77C-4738-85AC-18EC26F4976BQ38532037-844367E9-8CE3-4D8C-B09D-98F7CD472B70Q39023597-F64632B4-8038-41AC-A6D2-D7AF7A3A9BFDQ40332169-6D9187B6-8CA0-4C47-B4D6-025EB8DBCE8EQ42274607-188899F3-F5AB-4E8A-BFC9-7CE9F41DAA9CQ42376305-6A2955A8-FEFE-4AF4-83DA-4E65A5ECE42DQ48128395-6473B943-DB58-4723-AB9A-631C6F419F86Q51615851-DD18DE60-ACE0-424A-81F6-5BE94DFDD1D1Q55311835-99CB3AF3-C9E8-4549-AE36-CF6FECF87061
P2860
Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of vascular endothelial ...... T cells in vitro and in vivo.
@ast
Effect of vascular endothelial ...... T cells in vitro and in vivo.
@en
type
label
Effect of vascular endothelial ...... T cells in vitro and in vivo.
@ast
Effect of vascular endothelial ...... T cells in vitro and in vivo.
@en
prefLabel
Effect of vascular endothelial ...... T cells in vitro and in vivo.
@ast
Effect of vascular endothelial ...... T cells in vitro and in vivo.
@en
P2093
P2860
P1433
P1476
Effect of vascular endothelial ...... n T cells in vitro and in vivo
@en
P2093
Aninda Basu
Dipak Datta
Ingrid H C Vos
Katiana Calzadilla
Maria P Stack
Masayuki Sho
Monika Edelbauer
Peter Ganz
P2860
P304
P356
10.1182/BLOOD-2009-11-252460
P407
P577
2010-06-10T00:00:00Z